AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000;
1040-0605/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (494)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thannickal, V. J.
Right arrow Articles by Fanburg, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thannickal, V. J.
Right arrow Articles by Fanburg, B. L.
Vol. 279, Issue 6, L1005-L1028, December 2000

INVITED REVIEW
Reactive oxygen species in cell signaling

Victor J. Thannickal and Barry L. Fanburg

Pulmonary and Critical Care Division, Department of Medicine, New England Medical Center/Tupper Research Institute, Tufts University School of Medicine, Boston, Massachusetts 02111


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

Reactive oxygen species (ROS) are generated as by-products of cellular metabolism, primarily in the mitochondria. When cellular production of ROS overwhelms its antioxidant capacity, damage to cellular macromolecules such as lipids, protein, and DNA may ensue. Such a state of "oxidative stress" is thought to contribute to the pathogenesis of a number of human diseases including those of the lung. Recent studies have also implicated ROS that are generated by specialized plasma membrane oxidases in normal physiological signaling by growth factors and cytokines. In this review, we examine the evidence for ligand-induced generation of ROS, its cellular sources, and the signaling pathways that are activated. Emerging concepts on the mechanisms of signal transduction by ROS that involve alterations in cellular redox state and oxidative modifications of proteins are also discussed.

redox signaling; growth factors; cytokines; oxidation-reduction; free radicals


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

ALL MULTICELLULAR ORGANISMS depend on highly complex networks of both extracellular and intracellular signals to orchestrate cell-cell communication in diverse physiological processes such as developmental organogenesis, maintenance of normal tissue homeostasis, and repair responses to tissue injury. Typically, extracellular signals are composed of growth factors, cytokines, hormones, and neurotransmitters that bind to specific cell surface receptors. These receptor-ligand interactions then generate various types of intracellular signals that may involve changes in ion concentrations (ion channel-linked receptors), activation of trimeric GTP-binding regulatory proteins (G protein-coupled receptors), and activation of receptor kinases (enzyme-linked receptors). Downstream signaling is then relayed by second messengers (such as cAMP, Ca2+, and phospholipid metabolites) and by protein phosphorylation cascades. Ultimately, these intracellular signaling pathways lead to the activation of transcription factors that regulate the expression of specific sets of genes essential for diverse cellular functions.

Molecular oxygen (dioxygen; O2) is essential for the survival of all aerobic organisms. Aerobic energy metabolism is dependent on oxidative phosphorylation, a process by which the oxidoreduction energy of mitochondrial electron transport (via a multicomponent NADH dehydrogenase enzymatic complex) is converted to the high-energy phosphate bond of ATP. O2 serves as the final electron acceptor for cytochrome-c oxidase, the terminal enzymatic component of this mitochondrial enzymatic complex, that catalyzes the four-electron reduction of O2 to H2O. Partially reduced and highly reactive metabolites of O2 may be formed during these (and other) electron transfer reactions. These O2 metabolites include superoxide anion (O2-·) and hydrogen peroxide (H2O2), formed by one- and two-electron reductions of O2, respectively. In the presence of transition metal ions, the even more reactive hydroxyl radical (OH·) can be formed. These partially reduced metabolites of O2 are often referred to as "reactive oxygen species" (ROS) due to their higher reactivities relative to molecular O2.

ROS from mitochondria and other cellular sources have been traditionally regarded as toxic by-products of metabolism with the potential to cause damage to lipids, proteins, and DNA (78). To protect against the potentially damaging effects of ROS, cells possess several antioxidant enzymes such as superoxide dismutase (which reduces O2-· to H2O2), catalase, and glutathione peroxidase (which reduces H2O2 to H2O). Thus oxidative stress may be broadly defined as an imbalance between oxidant production and the antioxidant capacity of the cell to prevent oxidative injury. Oxidative stress has been implicated in a large number of human diseases including atherosclerosis, pulmonary fibrosis, cancer, neurodegenerative diseases, and aging (56, 103). Yet the relationship between oxidative stress and the pathobiology of these diseases is not clear, largely due to a lack of understanding of the mechanisms by which ROS function in both normal physiological and disease states.

Accumulating evidence suggests that ROS are not only injurious by-products of cellular metabolism but also essential participants in cell signaling and regulation (76, 237). Although this role for ROS is a relatively novel concept in vertebrates, there is strong evidence of a physiological role for ROS in several nonmammalian systems. In bacteria, the OxyR protein functions as a transcriptional regulator of H2O2-inducible genes and has been shown to be directly activated by oxidation (53, 278). A recent study (324) has shown that H2O2 oxidizes two conserved cysteines in OxyR to form intramolecular disulfide linkages that trigger the activation of this transcription factor, presumably by changing its conformation. The Escherichia coli SoxR transcription factor is activated specifically in response to O2-·-generating redox-cycling agents such as paraquat and menadione (95). Activated SoxR mediates SoxS gene transcription, resulting in an increase in SoxS protein that then activates the transcription of several other genes including superoxide dismutase (SOD) (63). SoxR is a homodimer that contains two redox-active iron-sulfur [2Fe-2S] centers that are sensitive to oxidation by O2-· (109, 312). The iron-sulfur centers of SoxR must be in their oxidized state for them to be transcriptionally active (85), thus providing a plausible mechanism by which O2-· transmits its gene regulatory signal. In plant cells, generation of H2O2 in response to various pathogens elicits localized cell death to limit spread of the pathogen (165) and a more systemic response involving the induction of defense genes regulating plant immunity (10). In sea urchins, fertilization triggers extracellular production of H2O2 by a plasma membrane oxidase with the simultaneous release of ovoperoxidase (263). Peroxidase- or H2O2-catalyzed cross-linking of extracellular proteins then forms a protective envelope around the freshly fertilized oocyte.

The apparent paradox in the roles of ROS as essential biomolecules in the regulation of cellular functions and as toxic by-products of metabolism may be, at least in part, related to differences in the concentrations of ROS produced. This is analogous to the effects of nitric oxide (NO·), which has both regulatory functions and cytotoxic effects depending on the enzymatic source and relative amount of NO· generated (210). NO· functions as a signaling molecule mediating vasodilation when produced in low concentrations by the constitutive isoform of nitric oxide synthase (NOS) in vascular endothelial cells (309) and as a source of highly toxic oxidants utilized for microbicidal killing when produced in high concentrations by inducible NOS in macrophages (178). Indeed, all phagocytic cells have a well-characterized O2-·-generating plasma membrane oxidase capable of producing the large amounts of ROS required for its function in host defense. In this review, we examine the evidence for the presence of similar plasma membrane oxidases that generate much lower amounts of ROS in nonphagocytic cells for purposes of cell signaling and regulation. We summarize the cellular effects of a wide range of ligand-receptor interactions that have been shown to generate intracellular or extracellular ROS. Emerging concepts on the mechanisms by which ROS may function as signaling molecules are discussed. For purposes of this review, we focus primarily on the cellular effects of ligand-mediated (endogenous) production of ROS rather than on the effects of exogenous oxidative stress. Also, the role of NO· as a signaling molecule is not discussed here except in the context of its ability to interact with and modulate O2-· signaling.


    CHEMISTRY OF ROS
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

The biological chemistries of ROS primarily determine the ability of different species to react with specific cellular substrates within the microenvironment in which they are produced. These ROS-substrate reactions are likely to form the basis for our understanding of ROS specificity and their mechanisms of action. ROS have often been "loosely" categorized as free radicals, but this is incorrect because not all ROS are free radicals. A free radical is defined as any atomic or molecular species capable of independent existence that contains one or more unpaired electrons in one of its molecular orbitals (102). Molecular O2 itself qualifies as a free radical because it has two unpaired electrons with parallel spin in different pi -antibonding orbitals. This spin restriction accounts for its relative stability and paramagnetic properties. O2 is capable of accepting electrons to its antibonding orbitals, becoming "reduced" in the process, and, therefore, functioning as a strong oxidizing agent.

A one-electron reduction of O2 results in the formation of O2-· either by enzymatic catalysis or by "electron leaks" from various electron transfer reactions. O2-· chemistry in aqueous solution differs greatly from that in organic solvents. In contrast to its remarkable stability in many organic solvents, O2-· in aqueous solution is short-lived. This "instability" in aqueous solutions is based on the rapid dismutation of O2-· to H2O2, a reaction facilitated by higher concentrations of the protonated form of O2-· (HO2·) in more acidic pH conditions. Thus the dismutation reaction has an overall rate constant of 5 × 105 M-1 · s-1 at pH 7.0. SOD speeds up this reaction almost 104-fold (rate constant = 1.6 × 109 M-1 · s-1) (79). This implies that any reaction of O2-· in aqueous solution will be in competition with SOD or, in its absence, with the spontaneous dismutation reaction itself. NO· reacts with O2-· at near diffusion-limited rates and is, therefore, one of the few biomolecules that is able to "outcompete" SOD for O2-· (119). Thus in most biological systems, unless sufficiently high concentrations of NO· or other similarly reactive molecules are present, generation of O2-· usually results in the formation of H2O2.

Although dismutation of O2-· probably accounts for much of the H2O2 produced by eukaryotic cells, H2O2 can also be formed by direct two-electron reduction of O2, a reaction mechanism shared by a number of flavoprotein oxidases (186). Unlike O2-·, H2O2 is not a free radical and is a much more stable molecule. H2O2 is able to diffuse across biological membranes, whereas O2-· does not. H2O2 is a weaker oxidizing agent than O2-·. However, in the presence of transition metals such as iron or copper, H2O2 can give rise to the indiscriminately reactive and toxic hydroxyl radical (OH·) by Fenton chemistry.


    CELLULAR SOURCES AND REGULATION OF ROS
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

Cellular production of ROS occurs from both enzymatic and nonenzymatic sources. As stated earlier, any electron-transferring protein or enzymatic system can result in the formation of ROS as "by-products" of electron transfer reactions. This "unintended" generation of ROS in mitochondria accounts for ~1-2% of total O2 consumption under reducing conditions (78). Due to high concentrations of mitochondrial SOD, the intramitochondrial concentrations of O2-· are maintained at very low steady-state levels (298). Thus unlike H2O2, which is capable of diffusing across the mitochondrial membrane into the cytoplasm (44), mitochondria-generated O2-· is unlikely to escape into the cytoplasm. The potential for mitochondrial ROS to mediate cell signaling has gained significant attention in recent years, particularly with regard to the regulation of apoptosis (25, 40, 46, 154, 166, 302). There is evidence to suggest that tumor necrosis factor (TNF)-alpha - and interleukin (IL)-1-induced apoptosis may involve mitochondria-derived ROS (269, 273, 311). It has also been suggested that the mitochondria may function as an "O2 sensor" to mediate hypoxia-induced gene transcription (45, 68).

The endoplasmic reticulum (ER) is another membrane-bound intracellular organelle that, unlike mitochondria, is primarily involved in lipid and protein biosynthesis. Smooth ER (lacking bound ribosomes) contains enzymes that catalyze a series of reactions to detoxify lipid-soluble drugs and other harmful metabolic products. The most extensively studied of these are the cytochrome P-450 and b5 families of enzymes that can oxidize unsaturated fatty acids and xenobiotics and reduce molecular O2 to produce O2-· and/or H2O2 (18, 43, 78). Although there does not appear to be a direct link between ER-derived oxidants and growth factor signaling, there is evidence for redox regulation of ER-related functions such as protein folding and secretion (22, 32, 120, 219). Bauskin et al. (32) showed that Ltk, a nonreceptor tyrosine kinase (non-RTK) expressed mainly in lymphocytes, leukemia cells, and neurons, is activated by forming disulfide-linked multimers in response to thiol-oxidizing agents. It has also been suggested that an O2-·-generating microsomal NADH oxidoreductase may function as a potential pulmonary artery O2 sensor in pulmonary artery smooth muscle cells (198, 199).

Nuclear membranes contain cytochrome oxidases and electron transport systems that resemble those of the ER but the function of which is unknown (78, 102). It has been postulated that electron "leaks" from these enzymatic systems may give rise to ROS that can damage cellular DNA in vivo (102).

Peroxisomes are an important source of total cellular H2O2 production (37). They contain a number of H2O2-generating enzymes including glycolate oxidase, D-amino acid oxidase, urate oxidase, L-alpha -hydroxyacid oxidase, and fatty acyl-CoA oxidase. Peroxisomal catalase utilizes H2O2 produced by these oxidases to oxidize a variety of other substrates in "peroxidative" reactions (296). These types of oxidative reactions are particularly important in liver and kidney cells in which peroxisomes detoxify a variety of toxic molecules (including ethanol) that enter the circulation. Another major function of the oxidative reactions carried out in peroxisomes is beta -oxidation of fatty acids, which in mammalian cells occurs in mitochondria and peroxisomes (9). Specific signaling roles have not been ascribed to peroxisome-derived oxidants, and only a small fraction of H2O2 generated in these intracellular organelles appears to escape peroxisomal catalase (37, 230).

In addition to intracellular membrane-associated oxidases, soluble enzymes such as xanthine oxidase, aldehyde oxidase, dihydroorotate dehydrogenase, flavoprotein dehydrogenase and tryptophan dioxygenase can generate ROS during catalytic cycling (78). The most extensively studied of these is the O2-·-generating xanthine oxidase, which can be formed from xanthine dehydrogenase after tissue exposure to hypoxia (188, 222). Xanthine oxidase is widely used to generate O2-· in vitro to study the effect of ROS on diverse cellular processes; however, no studies have implicated a direct physiological role for endogenous xanthine oxidase in cell signaling.

Autooxidation of small molecules such as dopamine, epinephrine, flavins, and hydroquinones can be an important source of intracellular ROS production (78). In most cases, the direct product of such autooxidation reactions is O2-·. Although there is no known role for autooxidation of small molecules in growth factor and/or cytokine signaling, such reactions may induce oxidative stress and alter the overall cellular redox state. There is the suggestion that the prooxidant effects of dopamine autooxidation may be involved in the dopamine-induced apoptosis that is implicated in the pathogenesis of neurodegenerative diseases such as Parkinson's disease (214, 215, 320).

Plasma membrane-associated oxidases have been implicated as the sources of most growth factor- and/or cytokine-stimulated oxidant production (97, 143, 191, 253, 280, 293), although the precise enzymatic sources have yet to be fully characterized. The best characterized of the plasma membrane oxidases in general is the phagocytic NADPH oxidase, which serves a specialized function in host defense against invading microorganisms (reviewed in Refs. 20, 258). This multicomponent enzyme catalyzes the one-electron reduction of O2 to O2-·, with NADPH as the electron donor through the transmembrane protein cytochrome b558 (a heterodimeric complex of gp91phox and p22phox protein subunits). The transfer of electrons occurs from NADPH on the inner aspect of the plasma membrane to O2 on the outside. During phagocytosis, the plasma membrane is internalized as the wall of the phagocytic vesicle, with what was once the outer membrane surface now facing the interior of the vesicle. This targets the delivery of O2-· and its reactive metabolites internally for localized microbicidal activity (20).

Recent studies (33, 81, 110, 127, 192, 200) have suggested that functional components of the phagocytic NADPH are present in nonphagocytic cells. Expression of p22phox has been demonstrated in the adventitial smooth muscle cells of coronary arteries (19) and the aorta (183). Moreover, polymorphism of the p22phox gene has been associated with an increased risk of coronary artery disease in young Caucasian men (84). Increased aortic adventitial O2-· production contributes to hypertension by blocking the vasodilatory effects of NO· (305). 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors appear to have a "cardioprotective" role not only by their effect on lowering cholesterol but also by inhibiting the activity of an O2-·-generating oxidase in vascular endothelial cells and, thereby, improving NO·-dependent vasodilation (303). Angiotensin II (ANG II)-induced hypertension is mediated, at least in part, by direct interactions between O2-·, generated by a NAD(P)H oxidase, and NO· in vascular smooth muscle cells (80). p22phox has been shown to be a functional component of this ANG II-stimulated oxidase (183, 322). TNF-alpha also stimulates O2-· production in vascular smooth muscle cells by a p22phox-based NADH oxidase and appears to upregulate p22phox gene expression in these cells (60). Both gp91phox and p22phox are expressed in pulmonary neuroepithelial cells where a NADPH oxidase-like enzyme may function as an O2 sensor by activating O2- and H2O2-sensitive K+ channels (304). However, it was later demonstrated that mice with chronic granulomatous disease (lacking a functional gp91phox subunit) have preserved hypoxic vasoconstrictive responses and O2 sensing, suggesting that this oxidase is not involved (14). More recently, Suh et al. (279) demonstrated that Mox-1, a gene encoding a homologue of the catalytic subunit of the phagocytic gp91phox, is expressed in a number of tissues including vascular smooth muscle. In this study, Mox-1 expression in NIH/3T3 cells was associated with increased O2-· production, serum-stimulated cell growth, and a transformed phenotype. This study suggests that an O2-·-generating oxidase similar (but not identical) to the phagocytic NADPH oxidase is present in some nonphagocytic cells where it functions primarily as a regulator of cellular growth responses.

Cytochrome b558, along with the cytosolic components p67phox, p47phox, and p40phox, makes up the core protein subunits of the phagocytic NADPH oxidase complex. Activation of the oxidase, however, requires the additional participation of Rac2 (or Rac1 in mouse macrophages) and Rap1A, members of the Ras superfamily of small GTP-binding proteins. During activation, Rac2 binds GTP and migrates to the plasma membrane along with the cytosolic components to form the active oxidase complex. A requirement for Rac1 in the activation of the mitogenic oxidase has also been demonstrated in nonphagocytic cells (55, 128). The insert region in Rac1 (residues 124-135) appears to be essential for O2-· production and stimulation of mitogenesis in quiescent fibroblasts but not for Rac1-induced cytoskeletal changes or activation of Jun kinase (128).

Another GTP-binding protein, p21Ras, appears to function upstream from Rac1 in oxidant-dependent mitogenic signaling (121, 281). Sundaresan et al. (281) showed that dominant negative expression of Rac1 inhibits not only the growth factor- and/or cytokine-generated rise in intracellular ROS in NIH/3T3 cells but also the ROS production in cells overexpressing a constitutively active isoform of Ras (H-RasV12). Stable transfection of the same Ras plasmid (H-RasV12) in fibroblasts induces cellular transformation and constitutive production of large amounts of O2-· (121). In this study, mitogenic signaling in Ras-transformed fibroblasts was demonstrated to be redox sensitive but independent of the mitogen-activated protein (MAP) kinase (MAPK) or c-Jun NH2-terminal kinase (JNK) pathways. Results from our laboratory (292) demonstrate the requirement for p21Ras in the generation of intracellular O2-· by mitogens such as platelet-derived growth factor (PDGF)-BB, fibroblast growth factor (FGF)-2, and transforming growth factor (TGF)-alpha in nontransformed human lung fibroblasts. However, studies from our laboratory (292, 293) also suggest the presence of a distinctly different ROS-generating enzymatic system in these cells that is independent of p21Ras regulation and that primarily generates extracellular H2O2 in response to TGF-beta 1.

In contrast to these relatively recent reports of pyridine- and flavin-linked oxidase activities in nonphagocytic cells, enzymes involved in phospholipid metabolism have been known to exist for several decades. Membrane phospholipids, in addition to their structural role in providing membrane integrity, are substrates for the action of the phospholipases (PLs) PLA2, PLC, and PLD. Although these enzymes are important for the generation of lipid second messengers, they have generally not been associated with ROS production in nonphagocytic cells. A recent report by Touyz and Schiffrin (297), however, suggests that ANG II-induced O2-· production in smooth muscle cells is dependent on the PLD pathway.

PLA2 hydrolyzes phospholipids to generate arachidonic acid. Arachidonic acid then forms the substrate for cyclooxygenase- and lipoxygenase (LOX)-dependent synthesis of the four major classes of eicosanoids: prostaglandins, prostacyclins, thromboxanes, and leukotrienes. These synthetic pathways involve a series of oxidation steps that involve a number of free radical intermediates (78). Arachidonic acid metabolism, particularly involving the LOX pathway, which leads to leukotriene synthesis, has been reported to generate ROS (30, 170, 207, 272). LOX activity has also been implicated in redox-regulated signaling by ANG II (306), epidermal growth factor (EGF) (196), and IL-1 (36). There is the suggestion that LOX-derived lipid peroxidation products may be involved in the oxidative stress response to asbestos (74). TNF-alpha -induced apoptosis appears to be mediated by a LOX-dependent but ROS-independent mechanism (213). A lipid-metabolizing enzyme in fibroblasts similar to 15-LOX has been shown to generate large amounts of extracellular O2-· that appears to be independent of flavoenzyme activity (212).


    MEASUREMENT OF ROS IN BIOLOGICAL SYSTEMS
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

The high reactivity and relative instability of ROS make them extremely difficult to detect or measure in biological systems. Thus assessments of ROS and free radical generation have largely been made by indirect measurement of various end products resulting from the interaction of ROS with cellular components such as lipids, protein, or DNA (78, 231). Most methods for identification of specific ROS are based on reactions with various "detector" molecules that are oxidatively modified to elicit luminescent or fluorescent signals. Although detailed descriptions of these methods are beyond the scope of this review, we briefly discuss the limitations of the more commonly used assays.

Lucigenin has been used extensively as a chemiluminescent substrate for the detection of O2-· in many biological systems (97, 101, 121, 168, 235, 274). This is based on the ability of lucigenin (Luc2+) to be reduced to LucH·+, which can then react with O2-· to yield an unstable dioxetane compound that yields light (emission of photons) in the process of spontaneously decomposing to its ground-state electronic configuration (73). It has recently been demonstrated (171) that several enzymatic systems in vitro are capable of univalently reducing Luc2+ even in the absence of O2-· generation, resulting in the formation of LucH·+ that can autooxidize to generate O2-·. The ability of lucigenin to "redox cycle" in this manner, much like the effects of paraquat and nitro blue tetrazolium, is thought to be a major limitation in the use of this compound in the detection of O2-· (171). However, the importance of this redox cycling effect of lucigenin when applied to biological systems has been questioned by other investigators (6, 168, 274). The use of an alternative chemiluminescent probe, coelenterazine, may present less of a concern with regard to the potential redox-cycling effects of these compounds (287).

Another technique that is widely used for the detection of intracellular H2O2 production in response to growth factor stimulation is based on oxidation of the nonfluorescent substrate 2',7'-dichlorofluorescin (DCFH) to the fluorescent product 2',7'-dichlorofluorescein (DCF) (24, 196, 280). The esterified form of DCFH, dichlorofluorescin diacetate (DCFH-DA), is able to cross cell membranes and then, as a result of deacetylation by intracellular esterases, forms DCFH, which becomes "trapped" intracellularly. This property allows for assessment of intracellular oxidant production. It is becoming increasingly clear, however, that this assay lacks specificity and may be a better indicator of overall changes in the intracellular redox state of the cell than a direct measure of intracellular H2O2 production (122, 247). Recent work (244, 245) also suggests that similar to the problem with lucigenin, a series of free radical chain reactions with DCFH in the presence of peroxidase (and even in the absence of H2O2) may give rise to "artificial" DCF-dependent fluorescence and O2 consumption.

Assessments of extracellular ROS production appear to be relatively more reliable and may allow for quantitative measurements. The method for detection of O2-· release with the method of SOD-inhibitable reduction of ferricytochrome c, initially described for neutrophils by Babior et al. (21), has been successfully used in other cell systems (187, 268). However, this method, although quite specific for O2-·, lacks sensitivity and may underestimate net O2-· production due to the potential reoxidation of ferricytochrome c by other oxidants (16).

Cellular production of extracellular H2O2 release can be measured by a fluorometric method that is based on the ability of heme peroxidases to catalyze H2O2-dependent dimerization of substituted phenolic compounds (221, 248). The major advantages of this method are its high specificity and sensitivity for H2O2 as determined with the use of horseradish peroxidase (used in most assays). The high sensitivity of such assays is related, at least in part, to the high reactivity of horseradish peroxidase (severalfold higher than catalase) with H2O2 (221). We (293) have been able to detect absolute concentrations of H2O2 in the 10-8 M range and a steady-state release of extracellular H2O2 of ~22 pmol · min-1 · 106 cells-1 from TGF-beta 1-treated fibroblasts in cell culture using this method. Because the fluorescence of the dimerized product is dependent on pH, careful consideration must be made for possible pH changes and overoxidation of the substrate (221).

The only analytic method that, at least theoretically, measures free radicals directly is electron spin resonance spectroscopy. However, it is relatively insensitive and requires steady-state concentrations in the micromolar range for detection and is, therefore, of limited value in most biological systems. This problem may be circumvented by the technique of spin trapping, which involves the addition of a "spin trap" (usually a nitrone or a nitroso compound) that reacts rapidly with free radicals to form more stable radical adducts that accumulate to concentrations in the detectable range (115, 240). Thus all of the currently available methods for the detection of ROS or free radicals in biological systems, including electron spin resonance spectroscopy, are, by definition, indirect (because detector compounds are required) and semiquantitative (because specific ROS are in competition with other biomolecules that can react with these detector molecules). However, if the redox chemistries of the various detector molecules are carefully considered and the potential limitations of these assays are understood, they can provide useful information on the production and regulation of ROS in biological systems.


    LIGAND-INDUCED ROS PRODUCTION IN NONPHAGOCYTIC CELLS
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

A variety of cytokines and growth factors that bind receptors of different classes have been reported to generate ROS in nonphagocytic cells (Table 1). Currently available information on the enzymatic source(s) and physiological actions of ROS generated by these ligand-receptor interactions are summarized here (see Fig. 1 for 3 such pathways).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Ligand-mediated generation of ROS in nonphagocytic cells



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1.   Proposed signaling pathways activated by specific ligand-mediated reactive oxygen species (ROS) production in nonphagocytic cells. A: mitogenic signaling by ROS in response to platelet-derived growth factor (PDGF) has been primarily studied in NIH/3T3 cells (121, 281), although a similar pathway may also be activated in vascular smooth muscle cells (280) and primary lung fibroblasts (292). One of the proposed mechanisms of this effect is ROS-mediated inactivation of protein tyrosine phosphatase (PTP)-1B (28, 163). EGF, epidermal growth factor; RTK, receptor tyrosine kinase. B: in primary lung fibroblasts, transforming growth factor (TGF)-beta 1 induces Src kinase(s)-dependent myofibroblast differentiation and activation of a cell surface-associated H2O2-generating NADH oxidase (292, 293, 295). * In mouse osteoblastic cells, TGF-beta 1-induced extracellular H2O2 has been shown to activate egr-1 in an autocrine manner (216). RS/TK, receptor serine/threonine kinase. C: in vascular smooth muscle cells, both angiotensin (ANG) II and serotonin [5-hydroxytryptamine (5-HT)] activate a NAD(P)H oxidase-like enzyme that generates intracellular ROS (97, 158). ROS-mediated activation of the p38 mitogen-activated protein kinase (MAPK) pathway appears to mediate ANG II-induced cell hypertrophy (299), whereas the extracellular signal-regulated kinase (ERK) 1/2 MAPK pathway mediates serotonin-induced cell proliferation (159). GPCR, G protein-coupled receptor; 5-HT TRP, 5-HT transporter. See text for details.

Cytokine receptors. Cytokine receptors fall into a large and heterogeneous group of receptors that lack intrinsic kinase activity and are not directly linked to ion channels or G proteins. Cytokines such as TNF-alpha , IL-1, and interferon (IFN)-gamma were among the first reported to generate ROS in nonphagocytic cells (187, 190, 191). There is no consensus on the specific species produced, the enzymatic source, or the site of generation of ROS for these cytokines. In the case of TNF-alpha , recent reports (49, 169, 257, 270, 319) suggest that a mitochondrial source of ROS is required for activation of the transcription factor nuclear factor (NF)-kappa B and NF-kappa B-dependent gene transcription. There is also the suggestion that TNF-alpha may activate NF-kappa B by an ROS-independent mechanism and that TNF-alpha and oxidants may produce a synergistic effect in this activation (126). TNF-alpha -induced generation of mitochondrial ROS has been implicated in apoptotic cell death (269). Overexpression of Mn SOD inhibits TNF-alpha -induced apoptosis, supporting a role for mitochondrial O2-· production in mediating this effect (181). The mechanism of TNF-alpha -induced apoptosis appears to be related, at least partially, to depletion of GSH, leading to redox-dependent formation of ceramide from sphingomyelin (172, 273). Gotoh and Cooper (94) showed that TNF-alpha activates apoptosis signal-regulating kinase-1 (ASK-1), a member of the MAPK kinase kinase superfamily, by inducing oxidant-dependent dimerization of ASK-1. The resistance to apoptosis in some cancer cells may be related to the constitutive activation of NF-kappa B by autocrine production of TNF-alpha (86). ROS-dependent mechanisms also appear to be involved in TNF-alpha -induced expression of cell adhesion molecules (12, 147, 233, 318), IL-8 expression (147, 266), production of chemokines (27, 62), and induction of cardiac myocyte hypertrophy (206).

Many of the redox-regulated effects of IL-1 on cell function appear to be similar to those of TNF-alpha . Both IL-1 and TNF-alpha have been implicated in playing a role in the cardioprotective effects of exercise by upregulating Mn SOD in a rat model of ischemia-reperfusion (316). These cytokines also upregulate heme oxygenase-1 in endothelial cells by redox-dependent mechanisms that involve protein kinase (PK) C, intracellular Ca2+, and PLA2 (289). IL-1, TNF-alpha , and H2O2 have been shown to induce insulin-like growth factor binding protein-1 synthesis in Hep G2 cells (152). In this study, the effect of cytokines, although sensitive to pyrrolidine dithiocarbamate, appears to be independent of endogenous ROS production. Bonizzi et al. (36) recently demonstrated three different cell-specific pathways leading to NF-kappa B activation by IL-1beta : a pathway dependent on ROS production by 5-LOX in lymphoid cells, a ROS- and 5-LOX-independent pathway in epithelial cells, and a pathway requiring ROS production by NADPH oxidase in monocytic cells. ROS-independent activation of NF-kappa B by IL-1beta in epithelial cells appears to involve the acidic sphingomyelinase/ceramide transduction pathway (228). There is evidence for flavoenzyme-generated ROS in the induction of c-Fos and collagenase expression by IL-1 in chondrocytes (175). Expression of collagenase by IL-1 may be mediated by an autocrine loop involving Rac1, ROS, and NF-kappa B in fibroblasts (136). IL-1 may inhibit fibrinolysis and contribute to vascular injury by inducing plasminogen activator inhibitor type 1 and type 1 collagen expression in a ROS-dependent manner in rat cardiac microvascular endothelial cells (217).

IFN-gamma is well recognized as an activator of the phagocytic NADPH oxidase that has an important role in defense against pathogenic bacteria (21). A recent report (146) suggests that IFN-gamma stimulates cyclooxygenase-dependent peroxide production in murine and human hepatocytes that confers resistance against bacterial growth. In contrast, a ROS-independent mechanism of endothelial cytoprotection from Candida albicans infection also appears to be mediated by IFN-gamma (77).

RTKs. A number of growth factors that bind RTKs have been shown to generate intracellular ROS essential for mitogenic signaling. A decade ago, PDGF was shown to stimulate cellular production of H2O2, which was thought to function as a "competence factor" in BALB/3T3 cell growth (264). Sundaresan et al. (280) demonstrated the ability of PDGF to transiently increase intracellular concentrations of H2O2, which was required for PDGF-induced tyrosine phosphorylation, MAPK activation, DNA synthesis, and chemotaxis. PDGF also activates the signal transducer and activator of transcription (STAT) family of transcription factors by a H2O2-dependent mechanism (271). Interestingly, H2O2 appears to antagonize the PDGF effect on disruption of gap junction communication by abrogating the phosphorylation of a gap junctional protein, connexin 43, by a tyrosine kinase- and redox-dependent mechanism (116). PDGF has also been shown to regulate gene expression by O2-·-dependent pathways. PDGF stimulates flavoenzyme-dependent O2-· generation in human aortic smooth muscle cells by PKC- and wortmannin-sensitive pathways (184). In this study, PDGF-induced O2-· production appears to participate in vascular lesion formation by activating NF-kappa B and inducing monocyte chemoattractant protein-1 expression. PDGF-induced O2-· (but not H2O2) appears to be involved in its upregulation of inducible NOS- and NO·-dependent release of PGE2 in fibroblasts (134).

Bae et al. (24) demonstrated that EGF-induced intracellular H2O2 formation in A547 cells requires EGF receptor kinase (but not the autophosphorylation sites on the EGF receptor) and that inhibition of protein tyrosine phosphatase activity by H2O2 is required for EGF-induced protein tyrosine phosphorylation. EGF has been shown to stimulate a rise in intracellular Ca2+ levels in a keratinocyte cell line followed by an increase in intracellular ROS and PLA2 activation (89, 90). In PC12 cells, EGF stimulates intracellular O2-· production, involving the LOX pathway, and this is attenuated by pretreatment of cells with nerve growth factor by a NO·-dependent mechanism (196). EGF-generated ROS were found to mediate inhibitory cross talk with a signaling pathway activated by a G protein-coupled receptor (323). Another member of the EGF family, heparin-binding EGF, stimulates intracellular ROS in vascular smooth muscle cells, and this is required for the autoinduction of its own mRNA (133). Exogenous oxidative stress also appears to stimulate secretion of heparin-binding EGF (48). Both EGF and PDGF stimulation of a mouse epidermal cell line (JB6) induce H2O2-dependent p70S6k activation that, by upregulating translation of a family of mRNA transcripts that encode for components of the protein synthetic machinery, is critical for cell cycle progression from the G0/G1 to the S phase (23). In transgenic mice overexpressing TGF-alpha (an EGF receptor ligand) and c-Myc in the liver, the observed overproduction of ROS by hepatocytes was proposed to account for the DNA damage and acceleration of hepatocarcinogenesis (71). EGF-enhanced tumorigenicity, metastatic capacity, and in vitro invasive capacity of a rat mammary carcinoma cell line (ER-1) have also been shown to be related, at least partially, to EGF-induced peroxide production (204).

Basic FGF (FGF-2) has been shown to stimulate a flavoprotein oxidase that generates the intracellular H2O2 required for the induction of c-Fos in chondrocytes (176). Our laboratory has shown that FGF-2 (in addition to other RTK-linked mitogens) generates O2-· in human lung fibroblasts (292). In this study, O2-· (preferentially over H2O2) appears to mediate a common mitogenic signaling by a number of RTK(s)-linked growth factors through a p21Ras-dependent pathway. Recently, hepatocyte growth factor (scatter factor) has also been shown to stimulate ROS in a sarcoma cell line where it appears to mediate an apoptotic, as opposed to a mitogenic, response (13).

Several RTK-linked growth factors have also been shown to have inhibitory effects on cellular ROS production. Heck et al. (106) showed that EGF downregulates the LPS- and cytokine-mediated H2O2 and NO· production in primary skin keratinocytes. Different members of the PDGF and FGF families, in an isoform-specific manner, appear to have either stimulatory or inhibitory effects on the activation of a H2O2-generating NADPH oxidase that has a role in adipocyte differentiation of 3T3 L1 cells (143). FGF-2 has also been shown to be neuroprotective by inhibiting beta -amyloid-induced ROS accumulation in hippocampal neurons (182). A similar neuroprotective effect is seen with nerve growth factor, which suppresses ROS production by a MAPK-dependent mechanism in a central nervous system neuronal cell line (67). These apparent opposing effects on ROS production may be related to tissue- and growth factor-specific actions.

Receptor serine/threonine kinases. All receptor serine/threonine kinases described to date in mammalian cells are members of the TGF-beta superfamily. TGF-beta 1 is the prototype of this large family of polypeptide growth factors that bind receptor serine/threonine kinases and include the TGF-beta s, activins, inhibins, bone morphogenetic proteins, and Mullerian-inhibiting substance (185, 227). Each member of the TGF-beta superfamily activates a heteromeric complex of type I-type II receptors in a combinatorial manner, leading to the phosphorylation and/or activation of the recently described SMAD proteins that translocate to the nucleus to mediate gene transcription (185). Unlike RTK(s)-linked growth factors, TGF-beta 1 typically inhibits growth of most target cells. Proliferative responses to TGF-beta 1 appear to be primarily related to the indirect effects on the autocrine production of mitogenic growth factors (29, 164) or their receptors (241, 291). These multifunctional effects of TGF-beta on cellular growth regulation as well its diverse effects on cell differentiation and extracellular matrix production are critical in complex biological processes such as embryogenesis, fibrosis, and carcinogenesis.

TGF-beta 1 has been shown to stimulate ROS production in a variety of cell types (123, 132, 251, 264, 293, 294). Shibanuma et al. (265) demonstrated a cell cycle-dependent extracellular release of H2O2 (only during the late G1 and not the G0 phase) from mouse osteoblastic cells stimulated with TGF-beta 1 in association with phosphorylation of a 30-kDa protein. It was proposed from this study that H2O2 was mediating the growth-inhibitory effects of TGF-beta 1. Another study from the same laboratory (216) examined intracellular ROS production in the same cell line and its role in the induction of the early growth response-1 (egr-1) gene by TGF-beta 1. In this study, extracellular catalase blocked both the TGF-beta 1-induced increase in intracellular H2O2 and egr-1 gene expression, leading the authors to propose that H2O2 may be released extracellularly before diffusing back into the cell. Studies from our laboratory (293, 294) support the concept that TGF-beta 1-stimulated H2O2 production is generated primarily extracellularly. In human lung fibroblasts, this effect appears to be mediated by activation of a flavoenzyme with cell surface-associated NADH:flavin:O2 oxidoreductase activity that is regulated by protein tyrosine phosphorylation (292, 294). More recent evidence (308) suggests that the assembly and activation of this oxidase complex require Src kinase(s) activation and actin cytoskeletal regulation.

TGF-beta 1 has also been shown to suppress the expression of antioxidant enzymes in some cells (123, 132). Kayanoki et al. (132) showed that TGF-beta 1 inhibits the expression of Mn SOD, copper-zinc SOD, and catalase in rat hepatocytes, leading to increased cellular oxidative stress. Arsalane et al. (15), Das et al. (58), and White et al. (308) have shown that TGF-beta 1 lowers cellular concentrations of intracellular glutathione (GSH) in some lung cells, primarily endothelial and epithelial cells. This appears to be mediated by an inhibitory effect of TGF-beta 1 on transcription of the rate-limiting enzyme involved in GSH synthesis, gamma -glutamylcysteine synthetase (15). The reduction in cellular GSH levels by TGF-beta 1 in vascular endothelial cells is closely associated with its growth-inhibitory effect and appears to be modulated by thiol availability (58). A recent study (59) suggests that intracellular levels of GSH may be important in discriminating an oxidative stress from a "signaling" response to TGF-beta 1. In this study, endogenously generated H2O2 appears to mediate TGF-beta 1 autoinduction but only under conditions in which intracellular GSH concentrations are high.

The specific molecular targets of TGF-beta -stimulated ROS are unknown, but its prooxidant effect on various cells has been proposed to regulate a number of physiological actions. These include its growth-inhibitory effects (58, 265), apoptosis (31, 105, 123, 145, 153, 251, 252), TGF-beta autoinduction (59), activation of latent TGF-beta (26), cellular transformation (129), collagen synthesis (83) and myofibroblast differentiation (59, 155).

G protein-coupled receptors. G protein-coupled receptors are the largest family of cell surface receptors, with >100 members characterized in mammals (9, 239). A number of ligands that bind to these receptors have been shown to generate ROS in different cell systems. Examples of these ligands include ANG II, serotonin [5-hydroxytryptamine (5-HT)], bradykinin, thrombin, and endothelin (ET).

ANG II is a vasoactive peptide that in addition to its effect on vasomotor tone, has proliferative and hypertrophic effects on vascular smooth muscle. ANG II has been shown to stimulate ROS production in cultured vascular smooth muscle cells (97, 297), glomerular mesangial cells (125), endothelial cells (288) and renal proximal tubular cells (104). Griendling et al. and Zafari et al. demonstrated that ANG II activates both NADH- and NADPH-dependent O2-· production in vascular smooth muscle cells (97) and that this activity requires the functional expression of p22phox (322). Physiological actions of ANG II that appear to be mediated by ROS include its vasopressor activity (235), smooth muscle cell hypertrophy (322), activation of cell survival PK Akt/PKB (300), induction of insulin-like growth factor-1 receptor (66), and IL-6 production (142). A recent study by Ushio-Fukai et al. (299) suggests that ANG II stimulates, in parallel, both p42/p44 and p38 MAPK pathways along with the generation of intracellular H2O2. However, in this study, only the p38 pathway was oxidant sensitive, and simultaneous inhibition of both pathways was required to block ANG II-induced cell hypertrophy, suggesting that there is cross talk between redox-sensitive and -insensitive MAPK pathways in mediating this effect.

5-HT, similar to ANG II, is a vasoactive peptide that mediates both cellular hypertrophy and hyperplasia in vascular smooth muscle cells (72, 160) while functioning as a neurotransmitter in neuronal cells. Although 5-HT binds to a number of different G protein-coupled receptors and other less well-characterized 5-HT receptors (9, 34), work from our laboratory (156, 161) suggests that its mitogenic effect on vascular smooth muscle cells is primarily related to the internalization of 5-HT through a 5-HT transporter protein. Intracellular transport of 5-HT induces tyrosine phosphorylation of GTPase-activating protein (157) that is associated with the generation of O2-· by a NAD(P)H-dependent oxidase activity required for mitogenic signaling (158, 162). A link between 5-HT transport and oxidant generation has also been reported in rat brain striatal tissue where activation of the 5-HT transporter mediates 3,4-methylenedioxymethamphetamine-induced generation of ROS and depletion of brain 5-HT (262). Recent work (159) demonstrates that in both smooth muscle cells (via the 5-HT transporter mechanism) and Chinese hamster lung fibroblasts (via both 5-HT transporter and receptor activation), the generation of 5-HT-induced O2-· leads to the activation of the p42/p44 MAPK pathway and cellular proliferation. A study by Grewal et al. (96) in mesangial cells suggests that a similar signaling pathway via the 5-HT2A receptor mediates PKC-dependent activation of a NAD(P)H oxidase that activates the p42/p44 MAPK pathway and TGF-beta 1 mRNA induction.

Unlike ANG II and 5-HT, bradykinin typically mediates vasodilation by the release of mediators such as NO· (220, 254). However, it has also been reported to generate ROS in vascular endothelial cells (114, 141, 267, 282) and human keratinocytes (89). The source of ROS production by bradykinin in endothelial cells appears to be associated with arachidonic acid metabolism involving either the PGH synthase pathway (140, 220) or the cyclooxygenase pathway (114, 267). Interestingly, work by Sobey et al. (275) suggests that the vasodilator responses of cerebral arterioles to bradykinin involve ROS-mediated activation of Ca2+-dependent K+ channels. Similar findings invoking a potential role for OH· in bradykinin-induced vasodilation of cerebral arterioles have been previously reported (242). However, a recent report (229) also suggests that an ROS-independent mechanism may mediate this effect.

Thrombin and ET-1 are potent vascular smooth muscle cell mitogens that also signal via G protein-coupled receptors (239). Thrombin has been shown to generate ROS in both endothelial cells (113) and smooth muscle cells (223, 236). Patterson et al. (223) recently demonstrated the ability of thrombin to stimulate O2-· and H2O2 production in vascular smooth muscle cells that is associated with the NAD(P)H oxidase activity required for thrombin-induced mitogenesis (223). In this study, thrombin increased expression of both p47phox and Rac2 in these cells and stimulated their translocation to the membrane, suggesting that an oxidase similar to the phagocytic NADPH oxidase is involved. In another study by Rao et al. (236), redox-dependent mitogenic signaling by thrombin in smooth muscle cells appears to involve extracellular signal-regulated kinase (ERK) 2, JNK1, and p38 MAPKs (because agonist-induced activation of all pathways was inhibited by N-acetylcysteine). However, in this study, only a subset of the early signaling events was dependent on oxidase activation because p38 MAPK and c-Fos/Jun B but not other pathways were inhibited by the flavoprotein inhibitor diphenyleneiodonium. Recently, ET-1 was also demonstrated to increase intracellular ROS production in cardiac myocytes by a p21Ras-dependent mechanism (50). In this study, the ET-1-induced ROS were essential for the induction of c-Fos expression. In another study, ROS also appear to mediate the inotropic effects of ET-1 on the myocardium (61).

Ion channel-linked receptors. Ion channel-linked receptors mediate rapid synaptic signaling between electrically excitable cells by transiently opening and closing an ion channel formed by the ligand-bound receptor complex. Such ligands typically are neurotransmitters (e.g., acetylcholine, 5-HT, glutamate, glycine, and gamma -aminobutyric acid). Compared with the other classes of receptors discussed above, relatively little is known about ROS signaling by ion channel-linked receptors. However, there is growing interest in the role of ROS in mediating neuronal cell death by some excitatory neurotransmitters. Glutamate induces ROS production in neuronal cells by mechanisms that have been shown to be both dependent and independent of the changes in intracellular ion concentrations (35, 260). Work by Sensi and colleagues (260, 261) suggests that ROS generation in these cells is a result of intracellular Zn2+-mediated mitochondrial depolarization. Acetylcholine has been shown to activate ATP-sensitive K+ channels and increase mitochondrial ROS that may function as an intracellular signal for acetylcholine-induced preconditioning in cardiomyocytes (317).


    SIGNALING MOLECULES "TARGETED" BY ROS
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS OF ROS ACTION
CONCLUSION
REFERENCES

Although a large number of signaling pathways appear to be regulated by ROS, the signaling molecules targeted by ROS are less clear. There is growing evidence, however, that redox regulation might occur at multiple levels in the signaling pathways from receptor to nucleus.

Receptor kinases and phosphatases themselves may be targets of oxidative stress. Growth factor receptors are most commonly activated by ligand-induced dimerization or oligomerization that autophosphorylates its cytoplasmic kinase domain (107). Ligand-independent clustering and activation of receptors in response to ultraviolet light have also been well demonstrated (243, 249), and this effect appears to be mediated by ROS (118, 226). Exogenous H2O2 (usually in the millimolar range) has been shown to induce tyrosine phosphorylation and activation of the PDGF-alpha , PDGF-beta , and EGF receptors (82, 87, 91). Lysophatidic acid-induced activation of the EGF receptor appears to be mediated by the intermediate formation of ROS (57). A study by Knebel et al. (138) suggests that the mechanism of these effects may be related to ROS-mediated inhibition of the dephosphorylation of RTKs by inactivation of membrane-bound protein tyrosine phosphatase(s). A similar action of either O2-·- or NO·-generating stimuli on the phosphorylation-dephosphorylation balance leading to PDGF receptor activation has also been reported (41). However, to our knowledge, no studies have demonstrated the ability of endogenous, growth factor-stimulated ROS to regulate its own (or other) receptor(s) activation. On the other hand, H2O2 production in response to EGF has been shown to require a functional EGF receptor kinase domain (24), suggesting that growth factor-induced ROS may function downstream from EGF receptor activation. This does not exclude the possibility that, under certain pathological conditions associated with oxidative stress, ROS may directly activate cell surface receptors.

Because most growth factors and cytokines appear to generate ROS at or near the plasma membrane, phospholipid metabolites are potentially important targets for redox signaling. Takekoshi et al. (286) showed that the oxidized forms of diacylglycerol were more effective in activating PKC than its nonoxidized forms. PKC activation and protein tyrosine phosphorylation appear to be required for H2O2-induced PLD activation in endothelial cells and fibroblasts (197, 209). This effect may be mediated by the upstream activation of growth factor receptors because suramin (an inhibitor of receptor activation) blocks H2O2-induced PLD activation (208). EGF signaling of PLA2 activation and arachidonic acid release is sensitive to antioxidants suggesting that PLA2 may be a target of ROS (88).

Non-RTKs belonging to the Src family (Src kinases) and Janus kinase (JAK) family have been reported to be regulated by various forms of oxidative stress (2, 7, 271). As in the case of RTKs, these reports relate primarily to the effects of exogenously added oxidants, and the significance of such actions in specific growth factor- or cytokine-mediated signaling is less clear. Simon et al. (271) have demonstrated, however, that PDGF-induced activation of the JAK-STAT pathway is redox sensitive, suggesting a role for endogenous oxidant production in mediating this effect. Src kinases and JAKs appear to be involved in H2O2-induced activation of p21Ras in fibroblasts (2). In another study, Lander et al. (150) have shown that p21Ras may be a common signaling target of NO· and ROS. This effect may involve the recruitment of phosphatidylinositol 3'-kinase to the plasma membrane where it associates directly with the effector domain of p21Ras before being activated (64).

ROS signaling by the induction of changes in intracellular Ca2+ ([Ca2+]i) has been studied in a number of cell types including smooth muscle cells (reviewed in Ref. 285). Roveri et al. (246) showed that H2O2 induces a rapid increase in [Ca2+]i that appears to be related to inositol 1,4,5-triphosphate-sensitive Ca2+ stores in the sarcoplasmic reticulum (SR) followed by a slower increase in [Ca2+]i that is most likely derived from the extracellular space (246). Both O2-· (98, 283, 284) and H2O2 (99) have been shown to inhibit the activity of ATP-dependent Ca2+ of the SR, which would result in passive diffusion of SR Ca2+ into the cytosol. Such effects may also be more important in oxidative stress responses (179) than in receptor-mediated signaling by growth factors and/or cytokines.

The MAPKs comprise a large family of PKs that include ERK1 (p44MAPK)/ERK2 (p42MAPK), JNKs (also known as the stress-activated PKs), and p38 MAPKs. Because the MAPK pathways mediate both mitogen- and stress-activated signals, there has been significant interest in the redox regulation of these pathways. A number of groups (4, 23, 100, 195, 201, 277) have demonstrated the ability of exogenous oxidants to activate the ERK MAPK pathway. The mechanism(s) for this effect is unclear, and the precise molecular target(s) is unknown. Some studies suggest that ROS-mediated ERK activation may be an upstream event at the level of growth factor receptors (100), Src kinases (7), and/or p21Ras (201). Another potential mechanism for this effect may be oxidant-induced inactivation of protein tyrosine phosphatases (PTPs) and/or protein phosphatase A (307). There are relatively fewer reports of endogenous ROS regulating the ERK MAPK pathway. However, Wilmer et al. (310) showed that IL-1-induced activation of ERK2 and JNK in human mesangial cells was inhibited by antioxidants, suggesting that ligand-stimulated ROS may be involved in mediating this effect. Also, serum- and 12-O-tetradecanoylphorbol-13-acetate-induced p21 induction appears to be mediated by redox-regulated ERK activation in HeLa cells (70). Results from our laboratory (159) suggest that redox regulation of the ERK pathway may be ligand and cell specific. 5-HT-induced ERK1/ERK2 activation in smooth muscle cells is redox sensitive, whereas FGF-2-stimulated activation of ERK1/ERK2 in lung fibroblasts is not (Thannickal et al., unpublished observations). Recent work also suggests that cyclin D1 expression, independent of the ERK MAPK pathway, may be a downstream target of redox-regulated mitogenic signaling (218). In vascular endothelial cells, cyclic strain-induced ROS can modulate egr-1 expression, at least partially, via the ERK signaling pathway (314).

Other members of the MAPK family have also been implicated as potential targets of ROS. Big MAPK-1 (BMK-1) appears to be much more sensitive than ERK1/ERK2 to H2O2 in several cell lines tested and suggests a potentially important role for BMK-1 as a redox-sensitive kinase (3). A study by Lo et al. (177) suggests that TNF-alpha - and IL-1-induced activation of JNK may be mediated by intracellular H2O2. ANG II (306) and EGF (17) have also been reported to have similar effects. Generation of ROS in response to hypoxia-reoxygenation and ischemia-reperfusion mediates JNK activation in cardiac myocytes (144) and perfused rat heart (54). Although not directly related to the MAPK family, p66shc, a splice variant of the p52shc/p46shc protein involved in mitogenic signaling from activated receptors to p21Ras, was found to be a target of H2O2 and responsible for mediating stress apoptotic responses (194).

NF-kappa B, a transcription factor that regulates the expression of a number of genes involved in immune and inflammatory responses, has long been considered oxidant responsive (193, 256). Significant progress has been made on the mechanisms of activation of this transcription factor, and the regulation of upstream Ikappa B kinases that phosphorylate Ikappa B, a critical step in NF-kappa B activation, has been recently characterized (130). However, the mechanism(s) by which ROS regulate this activity has remained elusive. Recent reviews (38, 167) on this subject have emphasized the importance of the recognition that a redox-dependent activation of NF-kappa B is cell and stimulus specific as opposed to the concept that oxidative stress is a common mediator of diverse NF-kappa B activators. Li and Karin (167) found that when a redox-regulated effect is observed, it appears to occur downstream from the Ikappa B kinases, at the level of ubiquitination and/or degradation of Ikappa B.

Activator protein-1 (AP-1), a transcriptional complex formed by the dimerization of Fos-Jun or Jun-Jun proteins, has also been demonstrated to be regulated by redox mechanisms. Both exogenous oxidants (11, 211) and ligand-induced ROS (176, 232) have been implicated in AP-1 activation. Unlike NF-kappa B, however, AP-1 appears also to be activated by some antioxidants (52, 321). In vitro experiments suggest that a single cysteine residue in the highly conserved tri-amino acid sequence Lys-Cys-Arg of the DNA binding domain of Fos and Jun proteins confers redox sensitivity to AP-1 (1). It was suggested from this study that this single cysteine residue was unlikely to account for the formation of inter- or intramolecular disulfide bonds but rather for the possible conversion of this cysteine to a reversible oxidation product such as sulfenic acid. Further evidence suggests that the redox regulation of AP-1 DNA binding is facilitated by the reducing activity of redox factor-1 (Ref-1) protein that may act directly on this critical cysteine residue (315). Other transcription factors in which DNA binding is regulated by similar redox mechanisms include Sp-1 (313), c-Myb (203), p53 (234) and egr-1 (117).


    MECHANISMS OF ROS ACTION
TOP
ABSTRACT
INTRODUCTION
CHEMISTRY OF ROS
CELLULAR SOURCES AND REGULATION...
MEASUREMENT OF ROS IN...
LIGAND-INDUCED ROS PRODUCTION...
SIGNALING MOLECULES "TARGETED"...
MECHANISMS O